UT Southwestern Medical Center SC - INC424B2401

Dallas, Texas 75390

We've found

1 trials

at this facility

Ruxolitinib Efficacy and Safety in Patients With HU Resistant or Intolerant Polycythemia Vera vs Best Available Therapy.

Status: Enrolling, Phase III
Updated: 12/4/2014

from

Dallas, TX

Use our guide to learn which trials are right for you!